CD4 and cryptococcosis: Clinical and experimental data have established that CD4+T-cell-mediated immunity (CMI) is essential for the control of cryptococcal infection since this disease occurs mainly in those with impaired CMI including HIV-infected individuals, with an incidence of 30% and a mortality of 30 to 60%2.